Cell & Gene Therapy

  1. Revolutionizing Plasmid Design With Trusted Expertise 4/11/2025

    Optimize your plasmid design to enhance performance, simplify scale-up, and meet your development goals with confidence.

  2. Overcoming Plasmid Design Challenges With Expert Support 4/11/2025

    Learn how strategic plasmid design and specialized consulting services can help overcome engineering challenges and accelerate therapeutic innovation.

  3. Transforming Viral Vector Manufacturing With Next-Generation CGMP Plasmids Platform 4/11/2025

    Watch as experts explore key innovations in plasmid design and production, highlighting how these advancements can directly enhance biomanufacturing workflows.

  4. CGMP-Validated RCL Assay Used For Release Testing Of Manufactured Viruses, Gene Mediated Cell Therapy Products 3/5/2025

    Ensure the safety and efficacy of lentiviral-based therapies by addressing the risks of replication-competent lentiviruses (RCLs) through advanced monitoring and control strategies.

  5. cGMP-Ready Clonal HEK293 Cell Line For AAV, Lentiviral, And Adenoviral Vector Production 11/7/2024

    See how this advanced SKPT-HEK293 4G9 was able to provide a robust, CGMP-ready solution for efficient viral vector production, supporting a range of AAV serotypes and CAR-T Lenti-viral vectors for scalable manufacturing.

  6. SK pharmteco Capacity Update October 2024: Cell & Gene Therapy 10/24/2024

    Check out our enhanced capacity and expertise in supporting CGT projects, offering end-to-end solutions from viral vector and plasmid development to GMP manufacturing and regulatory support.

  7. Cell And Gene Therapy Services 9/27/2024

    Fast-track your cell and gene therapies from cutting-edge process development to commercial success with advanced viral vector manufacturing solutions.

  8. Advancing Viral Vector Manufacturing: The Importance Of The Cell Line 9/16/2024

    Explore the pivotal role of cell lines in viral vector manufacturing, a complex, multi-step process that has traditionally been both time-consuming and labor-intensive.

  9. A Platform Approach To Accelerating Advanced Therapy Development And Manufacturing 9/16/2024

    Explore strategies for integrating cutting-edge technologies and optimizing unit operations to expedite the development and manufacturing of cell and gene therapies.

  10. Development Of A Universal, GMP-Ready, Clonal HEK293 Cell Line 9/16/2024

    When manufacturing adeno-associated virus, lenti- and adenoviral vectors, see how this HEK293 cell line is optimized for suspension culture and viral vector production, which can significantly reduce costs.